Zoetis Inc.’s Stock Price Takes a Dip to 149.98 USD: A Sharp 7.84% Decrease Shakes the Market

Zoetis Inc. (ZTS)

149.98 USD -12.75 (-7.84%) Volume: 11.53M

Explore the performance of Zoetis Inc.’s stock price, currently at 149.98 USD, experiencing a significant drop of -7.84% this trading session with a high trading volume of 11.53M. With a year-to-date percentage change of -24.01%, ZTS stock shows a dynamic market presence.

Latest developments on Zoetis Inc.

Animal health giant Zoetis Inc. (NYSE:ZTS) has been witnessing a significant downturn in its stock performance, plunging to a new 52-week low at $148.71. This comes in the wake of reports suggesting potential side effects of its pet arthritis drugs, allegedly leading to sickness in dogs and cats. The stock tumble, which saw Zoetis shares fall by 8% and led S&P 500 decliners, sparked off investigations into potential securities law violations. Despite these concerns, Zoetis continues its partnership with Horses for Mental Health as title sponsor, demonstrating its commitment to animal wellbeing.

A look at Zoetis Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

When looking at the long-term outlook for Zoetis, the Smartkarma Smart Scores provide valuable insights into various aspects of the company. With a Growth score of 4, Zoetis is positioned well for future expansion and development within the animal health industry. This indicates a positive outlook for the company’s ability to grow and innovate in the coming years.

On the other hand, Zoetis scored lower in Value and Resilience with scores of 2, indicating some challenges in terms of valuation and overall resilience. However, the company scored a 3 in Dividend and Momentum, showing stability in dividend payments and positive momentum in its market performance. Overall, Zoetis’ focus on animal health medicines and vaccines across different regions positions it as a key player in the industry with potential for growth and stability in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma